Editorial commentary: Targeting TYMP for cardiovascular disease: How far are we?
Trends Cardiovasc Med
.
2018 Apr;28(3):172-173.
doi: 10.1016/j.tcm.2017.12.002.
Epub 2017 Dec 7.
Author
Matteo Vatta
1
Affiliation
1
Invitae, San Francisco, CA; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN. Electronic address: matteo.vatta@invitae.com.
PMID:
29269286
DOI:
10.1016/j.tcm.2017.12.002
No abstract available
Publication types
Editorial
Comment
MeSH terms
Cardiovascular Diseases*
Humans
Thymidine Phosphorylase*
Substances
Thymidine Phosphorylase